Skip to main content

cisatracurium besylate

NDC 70710-1532 · Zydus Pharmaceuticals USA Inc.

Generic namecisatracurium besylate
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)CISATRACURIUM BESYLATE
Strength2 mg/mL
Pharmacologic classNeuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
Marketing categoryANDA

Packages

70710-1532-6 — 10 VIAL in 1 CARTON (70710-1532-6) / 5 mL in 1 VIAL (70710-1532-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

65145-135 — Cisatracurium besylate, 65145-136 — Cisatracurium besylate, 65145-137 — Cisatracurium besylate, 68083-486 — Cisatracurium besylate, 68083-487 — Cisatracurium besylate, 68083-488 — Cisatracurium besylate, 70069-141 — Cisatracurium Besylate, 70069-151 — Cisatracurium Besylate, 70069-161 — Cisatracurium Besylate, 70436-112 — Cisatracurium besylate, 70436-113 — Cisatracurium besylate, 70436-114 — Cisatracurium besylate, 70710-1534 — cisatracurium besylate, 71288-712 — Cisatracurium Besylate, 71288-713 — Cisatracurium Besylate, 71288-714 — Cisatracurium Besylate, 72485-513 — Cisatracurium Besylate, 72785-0008 — cisatracurium besylate, 72785-0009 — cisatracurium besylate, 83634-655 — cisatracurium besylate, +17 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels